Global Dosimetry Solutions, Inc., Names Sander Perle as Sr. VP Technical Operations

Costa Mesa, Calif., July 26, 2004 - Global Dosimetry Solutions, Inc. (GDS) a leading provider of dosimetry services (analytical determination of exposure to ionizing radiation) has announced the promotion of Sander Perle as Senior Vice President of Technical Operations. Formerly the Vice President of Technical Operations, Sandy was responsible for directing worldwide technical and regulatory activities. In his new capacity, he will play a broader role with respect to product development and corporate strategy.

Sandy has been a key member of the GDS team since joining the company in 1996. Prior to joining GDS, Sandy spent 21 years within the nuclear power industry and four years as a supervisor in a state radiological program. He is currently the Chair of the Health Physics Society Standards Committee; past Chair of the Electronic Media Committee; member of the Symposium Committee; sits on the ANSI N13.32 Working Group; serves as a member of the NCRP Corporate Resource Development Committee; and is Secretary for the Council on Ionizing Radiation Measurements and Standards (CIRMS). Sandy is also a NVLAP Technical Expert, and has been conducting on-site assessments since 1993. He holds a Bachelor of Science degree in Chemistry and a Master's degree in Radiological Physics from the University of Miami.

"Sandy is one of the leading experts in the dosimetry industry, " said Thomas Logan, CEO of Global Dosimetry." His experience and the respect he has earned throughout the community will be further leveraged as we continue to advance our leadership role in the industry."

Global Dosimetry Solutions, based in Irvine, California, is one of the world's largest providers of radiation dosimetry services. GDS offers a full range of services for measuring ionizing radiation primarily through film, thermoluminescent and track etch technologies. Since early 1970, the company has continually provided state-of-the-art personal radiation monitoring services to hospitals, medical and dental offices, university and national laboratories, nuclear power plants and other industries. GDS provides services to more than 500,000 people globally. Global Dosimetry Solutions is majority owned by American Capital Strategies, Ltd. (NASDAQ: ACAS), a $3.5 billion investment fund headquartered in Bethesda, Maryland. For more information, please visit: www.dosimetry.com.